Ameriprise
WINT

Ameriprise’s Windtree Therapeutics Inc WINT Stock Holding History

Ameriprise’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2
Closed – – 4907
2014
Q3 		$0 Hold
2
– – ﹤0.01% 5981
2014
Q2 		$0 Hold
2
– – ﹤0.01% 5750
2014
Q1 		$0 Hold
2
– – ﹤0.01% 5465
2013
Q4 		$0 Hold
2
– – ﹤0.01% 5605
2013
Q3 		$0 Hold
2
– – ﹤0.01% 5728
2013
Q2 		$0 Buy
+2
New +$49 ﹤0.01% 5603

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Ameriprise's WINT Position: Q4 2014 in Review

Ameriprise sold out of Windtree Therapeutics Inc (WINT) in Q4 2014, closing a stake of 2 shares.

Ameriprise first reported a position in WINT in Q2 2013 and held it in 6 quarters. The position peaked at $0 in Q3 2014. 56 funds tracked by Wall St. Rank hold WINT as of Q4 2014.

  • Ameriprise reported no remaining Windtree Therapeutics Inc position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 2 Windtree Therapeutics Inc shares in Q4 2014.
  • Ameriprise first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Windtree Therapeutics Inc position peaked at $0 in Q3 2014.
  • 56 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.